Karyopharm Therapeutics
KPTI
KPTI
50 hedge funds and large institutions have $19M invested in Karyopharm Therapeutics in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
13
Reduced
7
Closed
8
Calls
$1.61M
Puts
$127K
Net Calls
+$1.48M
Net Calls Change
+$995K
Top Buyers
Top Sellers
1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$587K |
2 |
Millennium Management
New York
|
-$101K |
3 |
SC
Shay Capital
New York
|
-$95.1K |
4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$88.4K |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43.2K |